Shahin Khashayar, Bouzari Majid, Wang Ran
Department of Biology, Faculty of Sciences, University of Isfahan, Hezar Jereeb Street, 81746-73441, Isfahan, Iran.
State Key Laboratory Cultivation Base of MOST, Institute of Food Safety and Nutrition, Jiangsu Academy of Agricultural Sciences, Nanjing 210014, PR China.
J Med Microbiol. 2018 Mar;67(3):376-386. doi: 10.1099/jmm.0.000683. Epub 2018 Jan 30.
Shigellosis is one of the most important food-borne and water-borne diseases worldwide. Although antibiotics are considered as efficient agents for shigellosis treatment, improper use of these has led to the emergence of antibiotic-resistant Shigella spp. Therefore, finding a new strategy as alternative treatment seems necessary.
Different samples from a wastewater treatment plant were used to isolate Shigella spp. specific phages. Physiological properties were determined, and genomic analysis was also carried out.
A virulent Siphoviridae bacteriophage, vB_SsoS-ISF002, was isolated from urban wastewater in Iran and showed infectivity to different isolates of both Shigella sonnei and Shigella flexneri. vB_SsoS-ISF002 was stable at different pH values and temperatures. It had a short latent period (15 min), a large burst size (76±9 p.f.u. cell) and appropriate lytic activity especially at high MOI. Its genome (dsDNA) was 50 564 bp with 45.53 % GC content and 76 predicted open reading frames. According to comparative genomic analysis and phylogenic tree construction, vB_SsoS-ISF002 was considered as a member of the T1virus genus.
These results indicated that vB_SsoS-ISF002 is a novel virulent T1virus phage and may have potential as an alternative treatment for shigellosis.
志贺氏菌病是全球最重要的食源性和水源性疾病之一。尽管抗生素被认为是治疗志贺氏菌病的有效药物,但这些药物的不当使用导致了耐药性志贺氏菌属的出现。因此,寻找一种新的替代治疗策略似乎很有必要。
使用来自污水处理厂的不同样本分离志贺氏菌属特异性噬菌体。测定了其生理特性,并进行了基因组分析。
从伊朗城市污水中分离出一种烈性长尾噬菌体科噬菌体vB_SsoS-ISF002,它对宋内志贺氏菌和福氏志贺氏菌的不同分离株均具有感染性。vB_SsoS-ISF002在不同的pH值和温度下都很稳定。它的潜伏期短(15分钟),裂解量高(76±9噬菌斑形成单位/细胞),尤其是在高感染复数时具有适当的裂解活性。其基因组(双链DNA)为50564 bp,GC含量为45.53%,预测有76个开放阅读框。根据比较基因组分析和系统发育树构建,vB_SsoS-ISF002被认为是T1病毒属的成员。
这些结果表明,vB_SsoS-ISF002是一种新型烈性T1病毒噬菌体,可能具有作为志贺氏菌病替代治疗方法的潜力。